SCHEMBL4377409

SCHEMBL4377409

O=C(COc1ccc2ccccc2c1)N1CCN(c2ccncc2)CC1

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.75
KMT2A Q03164 1/20 0.75
ALDH1A1 P00352 5/20 0.68
MAPT P10636 3/20 0.68
KDM4E B2RXH2 3/20 0.68
NPC1 O15118 1/20 0.67
HPGD P15428 1/20 0.67
RAB9A P51151 1/20 0.67
GAA P10253 2/20 0.66
LMNA P02545 1/20 0.66
ALOX15 P16050 1/20 0.66
CYP3A4 P08684 1/20 0.64
CYP2C9 P11712 1/20 0.64
CYP2C19 P33261 1/20 0.64
GPR183 P32249 1/20 0.63
HRH1 P35367 1/20 0.61
HRH3 Q9Y5N1 1/20 0.61
NPSR1 Q6W5P4 1/20 0.58
TP53 P04637 2/20 0.57
GLA P06280 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4377632 0.81 MAPK1 (0.75) MEN1KMT2AALDH1A1MAPTKDM4E
SCHEMBL4379155 0.81 ENPP2 (0.67) MEN1KMT2AALDH1A1MAPTGAA
SCHEMBL4379063 0.80 KDM4E (0.82) ALDH1A1MAPTKDM4ERAB9ALMNA
SCHEMBL4384247 0.80 HRH3 (0.66) ALDH1A1MAPTKDM4EGAALMNA
SCHEMBL1283182 0.79 ME2 (0.56) MEN1KMT2AALDH1A1MAPTKDM4E
SCHEMBL4377583 0.79 MAPT (0.77) ALDH1A1MAPTKDM4EHPGDGAA
SCHEMBL4376118 0.79 HRH3 (0.60) MAPTKDM4ELMNAHRH3NPSR1
SCHEMBL16825789 0.77 NPC1 (0.61) MEN1KMT2AALDH1A1MAPTKDM4E
SCHEMBL1374133 0.77 NPC1 (0.77) MEN1KMT2AALDH1A1MAPTKDM4E
SCHEMBL4378341 0.77 HTT (0.76) MEN1KMT2AALDH1A1MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1421071-B1 SUBSTITUTED PIPERAZINE AND DIAZEPANE DERIVAIVES AS HISTAMINE H3 RECEPTOR MODULATORS HIGH POINT PHARMACEUTICALS LLC (US) 2009-11-18 EP claimed
EP-1421071-B1 SUBSTITUTED PIPERAZINE AND DIAZEPANE DERIVAIVES AS HISTAMINE H3 RECEPTOR MODULATORS HIGH POINT PHARMACEUTICALS LLC (US) 2009-11-18 EP disclosed
EP-1421071-B1 SUBSTITUTED PIPERAZINE AND DIAZEPANE DERIVAIVES AS HISTAMINE H3 RECEPTOR MODULATORS HIGH POINT PHARMACEUTICALS LLC (US) 2009-11-18 EP disclosed
US-20080113968-A1 Substituted piperazines and diazepanes NOVO NORDISK A/S (DK) 2008-05-15 US disclosed
US-20080113968-A1 Substituted piperazines and diazepanes NOVO NORDISK A/S (DK) 2008-05-15 US disclosed
US-20080113968-A1 Substituted piperazines and diazepanes NOVO NORDISK A/S (DK) 2008-05-15 US disclosed
US-7208497-B2 Substituted piperazines and diazepanes NOVO NORDISK A/S (DK) 2007-04-24 US disclosed
US-7208497-B2 Substituted piperazines and diazepanes NOVO NORDISK A/S (DK) 2007-04-24 US disclosed
US-7208497-B2 Substituted piperazines and diazepanes NOVO NORDISK A/S (DK) 2007-04-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080113968-A1 Substituted piperazines and diazepanes HRH3, HRH4, HRH1 MEN1 2570/4885KMT2A 295/4885ALDH1A1 1907/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.